Rechallenging nivolumab following immune checkpoint inhibitor-induced pericarditis.

导出 OA

翻译打印收藏纠错

第一作者： Mustafa Rami,Ali

第一单位： Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.

作者： Mustafa Rami,Ali ^[1] ; Omar Jamil,Darwish ^[1] ; Laith,Alhuneafat ^[2] ; Bayan Nidal,Abdallah ^[3] ; Yacob,Saleh ^[1]

作者单位： Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan. ^[1] Department of Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania. ^[2] School of Medicine, The University of Jordan, Amman, Jordan. ^[3]

关键词 Adverse effects cardio-oncology immune checkpoint inhibitor management pericarditis

DOI 10.1080/08998280.2022.2132367

PMID 36578622

发布时间 2023-01-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Proceedings (Baylor University. Medical Center)

2023年36卷1期

83-84页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Rechallenging nivolumab following immune checkpoint inhibitor-induced pericarditis.

Proceedings (Baylor University. Medical Center)

相似文献

Proceedings (Baylor University. Medical Center)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Rechallenging nivolumab following immune checkpoint inhibitor-induced pericarditis.

Proceedings (Baylor University. Medical Center)

相似文献

Proceedings (Baylor University. Medical Center)

相关期刊

检索历史清除